<p>Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot Covid-19 vaccine in the country, <em>The Indian Express</em> <a href="https://bityl.co/6Jif)" target="_blank">reported</a> on Friday.</p>.<p>The US drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would "very shortly apply for permission to conduct clinical bridging trials in India," according to the report.</p>.<p><strong>Read more: <a href="https://www.deccanherald.com/science-and-environment/johnson-johnson-testing-covid-19-vaccine-on-teens-969669.html" target="_blank">Johnson & Johnson testing Covid-19 vaccine on teens </a></strong></p>.<p>The report comes as many vaccination centres in India grapple with a shortage of vaccine supplies as the country of 1.3 billion is battling a second wave of Covid-19 infections that has eclipsed the first. India's government, however, has repeatedly said there is no shortage of shots.</p>.<p>Johnson & Johnson and the CDSCO did not immediately respond to <em>Reuters </em>requests for comment.</p>.<p>India currently has two approved vaccines in use, one developed by Oxford University and AstraZeneca and the other, a shot from local player Bharat Biotech.</p>.<p>There are other vaccine candidates in trials in India including Russia's Sputnik-V, for which local drugmaker Dr Reddy's is currently conducting trials. Another shot developed by Cadila Healthcare Ltd is also in trials.</p>
<p>Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot Covid-19 vaccine in the country, <em>The Indian Express</em> <a href="https://bityl.co/6Jif)" target="_blank">reported</a> on Friday.</p>.<p>The US drugs and healthcare giant has sent a letter to India's Central Drugs Standard Control Organisation (CDSCO) saying it would "very shortly apply for permission to conduct clinical bridging trials in India," according to the report.</p>.<p><strong>Read more: <a href="https://www.deccanherald.com/science-and-environment/johnson-johnson-testing-covid-19-vaccine-on-teens-969669.html" target="_blank">Johnson & Johnson testing Covid-19 vaccine on teens </a></strong></p>.<p>The report comes as many vaccination centres in India grapple with a shortage of vaccine supplies as the country of 1.3 billion is battling a second wave of Covid-19 infections that has eclipsed the first. India's government, however, has repeatedly said there is no shortage of shots.</p>.<p>Johnson & Johnson and the CDSCO did not immediately respond to <em>Reuters </em>requests for comment.</p>.<p>India currently has two approved vaccines in use, one developed by Oxford University and AstraZeneca and the other, a shot from local player Bharat Biotech.</p>.<p>There are other vaccine candidates in trials in India including Russia's Sputnik-V, for which local drugmaker Dr Reddy's is currently conducting trials. Another shot developed by Cadila Healthcare Ltd is also in trials.</p>